Literature DB >> 6650749

Ebola virus infection in man: a serological and epidemiological survey in the Cameroons.

P Bouree, J F Bergmann.   

Abstract

The presence of antibodies to Ebola virus among 1,517 apparently healthy persons in five regions of the Cameroons was tested using indirect immunofluorescence. A positive rate of 9.7% was found, confirming that the virus circulates in the absence of clinical cases. Highest rates were found among Pygmies, young adults, and rain forest farmers.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6650749     DOI： 10.4269/ajtmh.1983.32.1465

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  14 in total

Review 1.  Strategies in Ebola virus disease (EVD) diagnostics at the point of care.

Authors:  Chad T Coarsey; Nwadiuto Esiobu; Ramswamy Narayanan; Mirjana Pavlovic; Hadi Shafiee; Waseem Asghar
Journal:  Crit Rev Microbiol       Date:  2017-04-25       Impact factor: 7.624

2.  Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo.

Authors:  Anna Bratcher; Nicole A Hoff; Reena H Doshi; Adva Gadoth; Megan Halbrook; Patrick Mukadi; Kamy Musene; Benoit Ilunga-Kebela; D'Andre Spencer; Matthew S Bramble; David McIlwan; J Daniel Kelly; Daniel Mukadi; Placide Mbala Kingebeni; Steve Ahuka; Emile Okitolonda-Wemakoy; Jean-Jacques Muyembe-Tamfum; Anne W Rimoin
Journal:  PLoS Negl Trop Dis       Date:  2021-08-12

3.  High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon.

Authors:  Pierre Becquart; Nadia Wauquier; Tanel Mahlakõiv; Dieudonné Nkoghe; Cindy Padilla; Marc Souris; Benjamin Ollomo; Jean-Paul Gonzalez; Xavier De Lamballerie; Mirdad Kazanji; Eric M Leroy
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

Review 4.  Immune barriers of Ebola virus infection.

Authors:  Anita K McElroy; Elke Mühlberger; César Muñoz-Fontela
Journal:  Curr Opin Virol       Date:  2018-02-16       Impact factor: 7.090

5.  Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.

Authors:  Daniel G Bausch; Matthias Borchert; Thomas Grein; Cathy Roth; Robert Swanepoel; Modeste L Libande; Antoine Talarmin; Eric Bertherat; Jean-Jacques Muyembe-Tamfum; Ben Tugume; Robert Colebunders; Kader M Kondé; Patricia Pirad; Loku L Olinda; Guénaël R Rodier; Patricia Campbell; Oyewale Tomori; Thomas G Ksiazek; Pierre E Rollin
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883

6.  Pygmy populations seronegative for Marburg virus.

Authors:  Matthias Borchert; Sabue Mulangu; Robert Swanepoel; Antoine Tshomba; Afongenda Afounde; Amayo Kulidri; Jean-Jacques Muyembe-Tamfum; Patrick Van der Stuyft
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

7.  Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo.

Authors:  Nanikaly Moyen; Laurence Thirion; Petra Emmerich; Amelia Dzia-Lepfoundzou; Hervé Richet; Yannik Boehmann; Yannick Dimi; Pierre Gallian; Ernest A Gould; Stephan Günther; Xavier de Lamballerie
Journal:  PLoS Negl Trop Dis       Date:  2015-06-05

Review 8.  How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence.

Authors:  Luke Nyakarahuka; Clovice Kankya; Randi Krontveit; Benjamin Mayer; Frank N Mwiine; Julius Lutwama; Eystein Skjerve
Journal:  BMC Infect Dis       Date:  2016-11-25       Impact factor: 3.090

Review 9.  A systematic review and meta-analysis of seroprevalence surveys of ebolavirus infection.

Authors:  Hilary Bower; Judith R Glynn
Journal:  Sci Data       Date:  2017-01-31       Impact factor: 6.444

10.  High prevalence of IgG antibodies to Ebola virus in the Efé pygmy population in the Watsa region, Democratic Republic of the Congo.

Authors:  Sabue Mulangu; Matthias Borchert; Janusz Paweska; Antoine Tshomba; Afongenda Afounde; Amayo Kulidri; Robert Swanepoel; Jean-Jacques Muyembe-Tamfum; Patrick Van der Stuyft
Journal:  BMC Infect Dis       Date:  2016-06-10       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.